Pharmacovigilance in Public Health

Pharmacovigilance in public health is a critical component of ensuring the safety and effectiveness of pharmaceutical products once they are on the market. It involves the systematic monitoring, assessment, and prevention of adverse effects or any other drug-related problems. Public health pharmacovigilance activities aim to protect the population from potential harm associated with the use of medications. Robust pharmacovigilance systems involve the collection and analysis of data from various sources, including healthcare professionals, patients, and regulatory agencies. Early detection of adverse drug reactions allows for timely intervention, minimizing risks and ensuring the continued safe use of medications. Pharmacovigilance contributes to evidence-based decision-making in healthcare by providing information on the risk-benefit profile of drugs. It plays a crucial role in post-marketing surveillance, detecting rare or long-term side effects that may not have been evident during pre-market clinical trials. Collaboration between regulatory authorities, healthcare providers, and the pharmaceutical industry is essential for the success of pharmacovigilance programs. Public awareness campaigns educate healthcare professionals and the public about the importance of reporting adverse drug reactions, fostering a culture of transparency and accountability. As new drugs are introduced and treatment patterns evolve, pharmacovigilance remains indispensable in maintaining the safety and integrity of public health pharmacotherapy.